BIIB
Biogen Inc. · Healthcare · Drug Manufacturers - General
Señales de momentum (gestores comparables):
amplitud de titulares +14.3% ·
flujo de acciones +5.4% ·
nuevas posiciones netas +12.5%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | -1 | 75.75K | $11.04M | n/a | −1 |
| Q2 2026 | 161 | 0 | 119.37M | $25.78B | +6 | −5 |
| Q1 2026 | 163 | -1 | 110.78M | $20.30B | +4 | −6 |
| Q4 2025 | 163 | 0 | 123.15M | $21.67B | +2 | −1 |
| Q3 2025 | 24 | +1 | 81.72M | $11.44B | +1 | −1 |
| Q2 2025 | 21 | 0 | 78.50M | $9.86B | n/a | n/a |
| Q1 2025 | 18 | +2 | 41.87M | $5.73B | +3 | −1 |
| Q4 2024 | 16 | -1 | 41.64M | $6.37B | n/a | −1 |
| Q3 2024 | 16 | +2 | 32.39M | $6.28B | +2 | n/a |
| Q2 2024 | 14 | n/a | 30.72M | $7.12B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 16.32M | -0.1% | $3.16B | 2.3% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 5.13M | -0.7% | $994.63M | 0.2% | ▼ Trim | 2 | SEC ↗ ×8 |
| 3 | Geode Capital Management ✦ (pasivo) | 3.61M | +1.3% | $698.06M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (pasivo) | 2.26M | +8.9% | $438.93M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.91M | -4.9% | $370.73M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 6 | Renaissance Technologies ✦ | 952.71K | +54.1% | $184.67M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 648.70K | +204.7% | $125.74M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 434.94K | +102.6% | $84.31M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Millennium Management ✦ | 398.14K | +66.0% | $77.17M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 372.37K | Nuevo | $72.18M | 0.1% | New | 1 | SEC ↗ ×2 |
| 11 | Bridgewater Associates ✦ | 72.10K | +339.2% | $13.98M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 66.77K | -2.5% | $12.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Marshall Wace ✦ | 66.30K | Nuevo | $12.85M | 0.0% | New | 1 | SEC ↗ ×2 |
| 14 | AQR Capital Management ✦ | 49.88K | +111.8% | $9.62M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 15 | Adage Capital Partners ✦ | 45.80K | -66.7% | $8.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 42.44K | +80.2% | $8.23M | 0.1% | ▲ Add | 2 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Citadel Advisors | $72.18M | 0.1% |
| Marshall Wace | $12.85M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 995 tenedores, 132.27M acciones, $23.30B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.